1. Home
  2. TSHA vs SPB Comparison

TSHA vs SPB Comparison

Compare TSHA & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • SPB
  • Stock Information
  • Founded
  • TSHA 2019
  • SPB 1906
  • Country
  • TSHA United States
  • SPB United States
  • Employees
  • TSHA N/A
  • SPB N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • SPB Industrial Machinery/Components
  • Sector
  • TSHA Health Care
  • SPB Miscellaneous
  • Exchange
  • TSHA Nasdaq
  • SPB Nasdaq
  • Market Cap
  • TSHA 1.4B
  • SPB 1.2B
  • IPO Year
  • TSHA 2020
  • SPB N/A
  • Fundamental
  • Price
  • TSHA $4.72
  • SPB $53.65
  • Analyst Decision
  • TSHA Strong Buy
  • SPB Strong Buy
  • Analyst Count
  • TSHA 8
  • SPB 4
  • Target Price
  • TSHA $9.63
  • SPB $79.50
  • AVG Volume (30 Days)
  • TSHA 11.3M
  • SPB 337.4K
  • Earning Date
  • TSHA 11-12-2025
  • SPB 11-14-2025
  • Dividend Yield
  • TSHA N/A
  • SPB 3.59%
  • EPS Growth
  • TSHA N/A
  • SPB N/A
  • EPS
  • TSHA N/A
  • SPB 2.71
  • Revenue
  • TSHA $8,098,000.00
  • SPB $2,849,200,000.00
  • Revenue This Year
  • TSHA N/A
  • SPB N/A
  • Revenue Next Year
  • TSHA N/A
  • SPB $0.77
  • P/E Ratio
  • TSHA N/A
  • SPB $23.80
  • Revenue Growth
  • TSHA N/A
  • SPB N/A
  • 52 Week Low
  • TSHA $1.05
  • SPB $49.99
  • 52 Week High
  • TSHA $5.51
  • SPB $96.62
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 59.56
  • SPB 52.85
  • Support Level
  • TSHA $4.80
  • SPB $49.99
  • Resistance Level
  • TSHA $5.51
  • SPB $55.32
  • Average True Range (ATR)
  • TSHA 0.44
  • SPB 1.32
  • MACD
  • TSHA 0.04
  • SPB 0.14
  • Stochastic Oscillator
  • TSHA 66.02
  • SPB 65.29

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: